BIOMAT Database Logo BIOMAT Database Logo

Correlation between MET gene copy number by silver in situ hybridization and protein expression by immunohistochemistry in non-small cell lung cancer. 2012

Rafal Dziadziuszko, and Murry W Wynes, and Shalini Singh, and Bernadette Reyna Asuncion, and James Ranger-Moore, and Krzysztof Konopa, and Witold Rzyman, and Barbara Szostakiewicz, and Jacek Jassem, and Fred R Hirsch
Medical University of Gdansk, Gdansk, Poland.

OBJECTIVE The MET receptor is involved in the pathogenesis and progression of non-small cell lung cancer (NSCLC). Clinical trials with MET inhibitors in NSCLC are planned with patient selection based on immunohistochemistry (IHC) and/or gene copy number assessment. Therefore, a detailed understanding of relationship between these markers and prognosis is essential. METHODS This study included tumors from 189 patients with NSCLC who underwent pulmonary resection (median follow-up, 5.3 years). MET expression was evaluated by IHC on tissue microarrays and scored according to hybrid (H) score (range: 0-400) and by scoring system used in the MetMAb trial (≥ 50% of cells with moderate or strong staining). MET gene copy number was assessed by silver in situ hybridization (n =140 patients). RESULTS Median MET IHC H score was 60 (range: 0-400; n =174). There were no associations between clinical and pathological characteristics, disease-free survival, and overall survival according to median value (p =0.36 and p =0.38, respectively), or other cut-points. According to MetMAb scoring criteria, IHC positivity rate was 25%, again with no associations to clinicopathological features or survival. In 140 tumors evaluable for MET copy number, 3 (2.1%) showed gene amplification and 14 (10%) had tumors with average of 5 or more copies per nucleus. There were no associations of MET copy number with clinical characteristics, disease-free survival, or overall survival with any analyzed cut-points. Correlation between MET copy number and protein expression was significant (Pearson's r =0.42, p < 0.0001). CONCLUSIONS There is a significant correlation between MET protein expression and MET gene copy number in operable NSCLC, but neither is associated with prognosis.

UI MeSH Term Description Entries
D007124 Immunoenzyme Techniques Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens. Antibody Enzyme Technique, Unlabeled,Enzyme Immunoassay,Enzyme-Labeled Antibody Technique,Immunoassay, Enzyme,Immunoperoxidase Techniques,Peroxidase-Antiperoxidase Complex Technique,Peroxidase-Labeled Antibody Technique,Antibody Enzyme Technic, Unlabeled,Enzyme-Labeled Antibody Technic,Immunoenzyme Technics,Immunoperoxidase Technics,Peroxidase-Antiperoxidase Complex Technic,Peroxidase-Labeled Antibody Technic,Antibody Technic, Enzyme-Labeled,Antibody Technic, Peroxidase-Labeled,Antibody Technics, Enzyme-Labeled,Antibody Technics, Peroxidase-Labeled,Antibody Technique, Enzyme-Labeled,Antibody Technique, Peroxidase-Labeled,Antibody Techniques, Enzyme-Labeled,Antibody Techniques, Peroxidase-Labeled,Enzyme Immunoassays,Enzyme Labeled Antibody Technic,Enzyme Labeled Antibody Technique,Enzyme-Labeled Antibody Technics,Enzyme-Labeled Antibody Techniques,Immunoassays, Enzyme,Immunoenzyme Technic,Immunoenzyme Technique,Immunoperoxidase Technic,Immunoperoxidase Technique,Peroxidase Antiperoxidase Complex Technic,Peroxidase Antiperoxidase Complex Technique,Peroxidase Labeled Antibody Technic,Peroxidase Labeled Antibody Technique,Peroxidase-Antiperoxidase Complex Technics,Peroxidase-Antiperoxidase Complex Techniques,Peroxidase-Labeled Antibody Technics,Peroxidase-Labeled Antibody Techniques,Technic, Enzyme-Labeled Antibody,Technic, Immunoenzyme,Technic, Immunoperoxidase,Technic, Peroxidase-Antiperoxidase Complex,Technic, Peroxidase-Labeled Antibody,Technics, Enzyme-Labeled Antibody,Technics, Immunoenzyme,Technics, Immunoperoxidase,Technics, Peroxidase-Antiperoxidase Complex,Technics, Peroxidase-Labeled Antibody,Technique, Enzyme-Labeled Antibody,Technique, Immunoenzyme,Technique, Immunoperoxidase,Technique, Peroxidase-Antiperoxidase Complex,Technique, Peroxidase-Labeled Antibody,Techniques, Enzyme-Labeled Antibody,Techniques, Immunoenzyme,Techniques, Immunoperoxidase,Techniques, Peroxidase-Antiperoxidase Complex,Techniques, Peroxidase-Labeled Antibody
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D005260 Female Females

Related Publications

Rafal Dziadziuszko, and Murry W Wynes, and Shalini Singh, and Bernadette Reyna Asuncion, and James Ranger-Moore, and Krzysztof Konopa, and Witold Rzyman, and Barbara Szostakiewicz, and Jacek Jassem, and Fred R Hirsch
c-MET/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomas.
February 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,
Rafal Dziadziuszko, and Murry W Wynes, and Shalini Singh, and Bernadette Reyna Asuncion, and James Ranger-Moore, and Krzysztof Konopa, and Witold Rzyman, and Barbara Szostakiewicz, and Jacek Jassem, and Fred R Hirsch
Silver-enhanced in situ hybridization for determination of EGFR copy number alterations in non-small cell lung cancer.
December 2012, The American journal of surgical pathology,
Rafal Dziadziuszko, and Murry W Wynes, and Shalini Singh, and Bernadette Reyna Asuncion, and James Ranger-Moore, and Krzysztof Konopa, and Witold Rzyman, and Barbara Szostakiewicz, and Jacek Jassem, and Fred R Hirsch
MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC).
June 2015, Oncotarget,
Rafal Dziadziuszko, and Murry W Wynes, and Shalini Singh, and Bernadette Reyna Asuncion, and James Ranger-Moore, and Krzysztof Konopa, and Witold Rzyman, and Barbara Szostakiewicz, and Jacek Jassem, and Fred R Hirsch
Alterations of MET Gene Copy Number and Protein Expression in Primary Non-Small-Cell Lung Cancer and Corresponding Nodal Metastases.
January 2016, Clinical lung cancer,
Rafal Dziadziuszko, and Murry W Wynes, and Shalini Singh, and Bernadette Reyna Asuncion, and James Ranger-Moore, and Krzysztof Konopa, and Witold Rzyman, and Barbara Szostakiewicz, and Jacek Jassem, and Fred R Hirsch
Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer.
May 2013, Journal of biomedical research,
Rafal Dziadziuszko, and Murry W Wynes, and Shalini Singh, and Bernadette Reyna Asuncion, and James Ranger-Moore, and Krzysztof Konopa, and Witold Rzyman, and Barbara Szostakiewicz, and Jacek Jassem, and Fred R Hirsch
Correlation between MET protein expression and MET gene copy number in a Caucasian cohort of non-small cell lung cancers according to the new IASLC/ATS/ERS classification.
June 2015, Pathology,
Rafal Dziadziuszko, and Murry W Wynes, and Shalini Singh, and Bernadette Reyna Asuncion, and James Ranger-Moore, and Krzysztof Konopa, and Witold Rzyman, and Barbara Szostakiewicz, and Jacek Jassem, and Fred R Hirsch
[Clinicopathological features and prognostic implications of EGFR/c-Met gene copy number and protein expression in non-small cell lung cancer].
November 2010, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Rafal Dziadziuszko, and Murry W Wynes, and Shalini Singh, and Bernadette Reyna Asuncion, and James Ranger-Moore, and Krzysztof Konopa, and Witold Rzyman, and Barbara Szostakiewicz, and Jacek Jassem, and Fred R Hirsch
Concordance analysis between HER2 immunohistochemistry and in situ hybridization in non-small cell lung cancer.
January 2018, The International journal of biological markers,
Rafal Dziadziuszko, and Murry W Wynes, and Shalini Singh, and Bernadette Reyna Asuncion, and James Ranger-Moore, and Krzysztof Konopa, and Witold Rzyman, and Barbara Szostakiewicz, and Jacek Jassem, and Fred R Hirsch
Correlation between encoded protein overexpression and copy number of the HER2 gene with survival in non-small cell lung cancer.
January 2003, International journal of cancer,
Rafal Dziadziuszko, and Murry W Wynes, and Shalini Singh, and Bernadette Reyna Asuncion, and James Ranger-Moore, and Krzysztof Konopa, and Witold Rzyman, and Barbara Szostakiewicz, and Jacek Jassem, and Fred R Hirsch
Met gene copy number predicts the prognosis for completely resected non-small cell lung cancer.
November 2008, Cancer science,
Copied contents to your clipboard!